European Investment Bank

Activity from announced rounds

Activity in this selectionmicron-technology-f1ebc71f
Rounds participated in
7
Confirmed lead rounds
0
2 roles undisclosed
New companies
7
First participation on record · 0 follow-on
Funding in participating rounds
$1.6B
5 disclosed · full round size, not this investor’s share

By stage

Undisclosed3
Series C+2
Growth1
Series B1

By primary sector

Healthtech4
Climate tech1
Industrial tech1
Robotics1

By country

Italy3
France1
Germany1
Netherlands1
United Kingdom1

Rounds

7 in this selection
Reactive Technologies

Reactive Technologies measures grid inertia and other stability conditions in real time, helping system operators see where renewable-heavy networks are vulnerable and plan or respond with better data.

€19MEIB venture debt
Participant
Morphotonics

Morphotonics makes large-area nanoimprint lithography equipment for manufacturers of optical components, including display waveguides and data-center photonics.

UndisclosedSeries B close
Participant
HighLife

HighLife Medical develops a transcatheter mitral-valve replacement system designed to treat patients with severe mitral regurgitation without open-heart surgery.

€80MFinancing round
Participant
MMI

Medical Microinstruments (MMI) makes the Symani robotic microsurgery system for surgeons treating patients who need reconstructive microsurgery or supermicrosurgery. Its wristed instruments scale and steady surgeons’ hand movements for precise work on very small blood vessels and soft tissue.

€17M€17 million co-investment
Participant
Tensive

Clinical-stage bioresorbable implants designed to support natural breast-tissue regeneration and mark the tumour bed after lumpectomy.

≤€20MConvertible venture debt
Participant
WISE

Develops advanced implantable electrodes for neuromonitoring, neuromodulation, and brain-computer interfaces

€30MSeries D
Role not disclosed
NEURA Robotics

Builds cognitive humanoid robots and shared Physical AI infrastructure for real-world industrial and commercial deployment

$1.4BSeries C
Role not disclosed